Clinical Trial Update: Efficacy, Safety and Pharmacokinetics of Teriflunomide in Pediatric Patients With Relapsing Forms of Multiple Sclerosis [Phase 3]

View source ↗

Summary

Phase 3 pediatric trial evaluating efficacy, safety, and pharmacokinetics of teriflunomide in children with relapsing forms of multiple sclerosis; results compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Teriflunomide (teriflunomide)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Multiple Sclerosis | Phase 3 | Status: COMPLETED | Results posted: 2020-11-30